Undoubtedly, we question a possible pathogenetic role of hyperprolactinemia in the onset of hypogonadism in patients with COVID-19 because these patients also have significantly elevated LH levels, whereas hyperprolactinemia is known to be associated with low or inappropriately low LH levels. This evidence concerns the gene PLOD1 and COVID-19.